Race and economic disparities significantly affect lung cancer treatment and outcomes with worse outcomes seen in Black and ...

Most patients with persistent pulmonary symptoms after recovering from mild to moderate COVID-19 infection have normal ...

A significant percentage of patients with GCA present with atypical, nonclassical organ manifestations, including cardiac involvement and respiratory disease.

Vaping-related disorder is rare in patients with chronic lung disease but is also associated with a much higher likelihood of ...

Roughly 6 months after starting tezepelumab for severe asthma, many patients reduced OCS dependence and meaningfully improved ...

Asthma clinical remission among patients taking dupilumab is most likely to occur in those with increased baseline BEC and FeNO levels.

Adding paridiprubart to standard care in ICU patients with COVID respiratory distress may reduce invasive support needs and allow earlier discharge.

Prior COVID-19 infection was not independently associated with an increased risk for upper respiratory tract infections in adults.

Among ICU patients with cirrhosis and sepsis, a high lactate-to-hematocrit ratio predicted short- and long-term mortality.

Tirzepatide treatment may lead to OSA remission or mild nonsymptomatic OSA in patients with moderate to severe OSA and obesity.

Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.

CHEST 2025, the 90th annual meeting of the American College of Chest Physicians, opens on "Love Your Lungs Day" on October 19 in Chicago.